Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Breast Cancer

  Free Subscription

Articles published in Radiother Oncol

Retrieve available abstracts of 74 articles:
HTML format

Single Articles

    June 2024
  1. CHRIST SM, Alongi F, Ricardi U, Scorsetti M, et al
    Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E(2)-RADIatE OligoCare study.
    Radiother Oncol. 2024;195:110235.
    PubMed     Abstract available

    May 2024
  2. HANNOUN-LEVI JM, Gimeno Morales M, Gal J, Anchuelo J, et al
    Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort.
    Radiother Oncol. 2024;194:110217.
    PubMed     Abstract available

  3. CICCHETTI A, Mangili P, Fodor A, Gabellini MGU, et al
    Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy.
    Radiother Oncol. 2024;194:110183.
    PubMed     Abstract available

    March 2024
  4. FRANCESCHINI D, Franzese C, Comito T, Ilieva MB, et al
    Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
    Radiother Oncol. 2024;195:110240.
    PubMed     Abstract available

  5. HUIJSKENS S, Granton P, Fremeijer K, van Wanrooij C, et al
    Clinical practicality and patient performance for surface-guided automated VMAT gating for DIBH breast cancer radiotherapy.
    Radiother Oncol. 2024 Mar 14:110229. doi: 10.1016/j.radonc.2024.110229.
    PubMed     Abstract available

  6. KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
    Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
    Radiother Oncol. 2024;194:110188.

  7. HOGSBJERG KW, Maae E, Nielsen MH, Stenbygaard L, et al
    Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial.
    Radiother Oncol. 2024 Mar 3:110195. doi: 10.1016/j.radonc.2024.110195.
    PubMed     Abstract available

  8. GIMENO-MORALES M, Martinez-Monge R, Martinez-Lage A, Jablonska PA, et al
    Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients.
    Radiother Oncol. 2024;194:110193.
    PubMed     Abstract available

    February 2024
  9. RAUFF SONDERGAARD S, Bechmann T, Maae E, Molby Nielsen AW, et al
    Shared decision making with breast cancer patients - does it work? Results of the cluster-randomized, multicenter DBCG RT SDM trial.
    Radiother Oncol. 2024 Feb 3:110115. doi: 10.1016/j.radonc.2024.110115.
    PubMed     Abstract available

  10. WINTRAECKEN VM, Boersma LJ, van Roozendaal LM, de Vries J, et al
    Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial.
    Radiother Oncol. 2024;191:110069.
    PubMed     Abstract available

  11. OLLONI A, Lorenzen EL, Jeppesen SS, Diederichsen A, et al
    An open source auto-segmentation algorithm for delineating heart and substructures - Development and validation within a multicenter lung cancer cohort.
    Radiother Oncol. 2024;191:110065.
    PubMed     Abstract available

    January 2024
  12. WHELAN TJ, Fyles A, Parpia S, Nielsen T, et al
    LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy.
    Radiother Oncol. 2024;190:110074.
    PubMed     Abstract available

  13. MEATTINI I, Marta GN, Carroll S, Rivera S, et al
    Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question.
    Radiother Oncol. 2024;190:110045.
    PubMed     Abstract available

    December 2023
  14. SUK CHANG J, Lee J, Vicini FA, Sung Kim J, et al
    Large Institutional Experience of Early Outcomes and Dosimetric Findings with Postoperative Stereotactic Partial Breast Irradiation in Breast Cancer.
    Radiother Oncol. 2023 Dec 22:110066. doi: 10.1016/j.radonc.2023.110066.
    PubMed     Abstract available

  15. KAIDAR-PERSON O, Meattini I, Boersma LJ, Becherini C, et al
    Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European SocieTy for Radiotherapy and Oncology (ESTRO).
    Radiother Oncol. 2023 Dec 18:110060. doi: 10.1016/j.radonc.2023.110060.
    PubMed     Abstract available

    November 2023
  16. BUSSCHAERT SL, Kimpe E, Barbe K, De Ridder M, et al
    Introduction of ultra-hypofractionation in breast cancer: implications for costs and resource use.
    Radiother Oncol. 2023 Nov 11:110010. doi: 10.1016/j.radonc.2023.110010.
    PubMed     Abstract available

  17. YEONG SONG J, Guk Han M, Kim Y, Ji Kim M, et al
    Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model.
    Radiother Oncol. 2023 Nov 2:109981. doi: 10.1016/j.radonc.2023.109981.
    PubMed     Abstract available

    October 2023
  18. CHEN M, Xiao L, Jia H, Wang S, et al
    Stereotactic ablative radiotherapy and FAPalpha-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer.
    Radiother Oncol. 2023 Oct 6:109946. doi: 10.1016/j.radonc.2023.109946.
    PubMed     Abstract available

    September 2023
  19. SALVESTRINI V, Kim K, Caini S, Alkner S, et al
    Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis.
    Radiother Oncol. 2023;186:109805.
    PubMed     Abstract available

    August 2023
  20. AZNAR MC, Carrasco de Fez P, Corradini S, Mast M, et al
    ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy.
    Radiother Oncol. 2023;185:109734.
    PubMed     Abstract available

  21. FAYDA M
    Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients.
    Radiother Oncol. 2023;185:109722.

  22. KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
    Safety and Feasibility of CDK4/6 Inhibitors Treatment Combined with Radiotherapy in Patients with HR-positive/HER2-negative Breast Cancer A Systematic Review and Meta-analysis.
    Radiother Oncol. 2023 Aug 1:109839. doi: 10.1016/j.radonc.2023.109839.
    PubMed     Abstract available

    July 2023
  23. LE BRAS A, Belkacemi Y, Bourgier C, Gabelle-Flandin I, et al
    Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized
    Radiother Oncol. 2023 Jul 20:109818. doi: 10.1016/j.radonc.2023.109818.
    PubMed     Abstract available

  24. JANDU HK, Veal CD, Fachal L, Luccarini C, et al
    Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
    Radiother Oncol. 2023 Jul 10:109806. doi: 10.1016/j.radonc.2023.109806.
    PubMed     Abstract available

    June 2023
  25. LOUISE HOLM MILO M, Vrou Offersen B
    Response to "letter to the Editor of Radiotherapy and Oncology regarding the paper titled Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation the
    Radiother Oncol. 2023 Jun 14:109733. doi: 10.1016/j.radonc.2023.109733.

    May 2023
  26. SAIFI O, Zeidan YH
    One Size Does Not Fit All: PMRT in ypN0 HER-2 Positive Breast Cancer.
    Radiother Oncol. 2023 May 25:109725. doi: 10.1016/j.radonc.2023.109725.

  27. KAIDAR-PERSON O, Giasafaki P, Boersma L, De Brouwer P, et al
    Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925.
    Radiother Oncol. 2023;185:109698.
    PubMed     Abstract available

    April 2023
  28. SAIFI O, Bachir B, Panoff J, Poortmans P, et al
    Post-mastectomy Radiation Therapy in HER-2 Positive Breast Cancer after Primary Systemic Therapy: Pooled Analysis of TRYPHAENA and NeoSphere Trials.
    Radiother Oncol. 2023 Apr 6:109668. doi: 10.1016/j.radonc.2023.109668.
    PubMed     Abstract available

    March 2023
  29. SONG YC, Kong J, Li N, Liu XL, et al
    Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: a multicenter retrospective study.
    Radiother Oncol. 2023 Mar 27:109639. doi: 10.1016/j.radonc.2023.109639.
    PubMed     Abstract available

  30. VEKEN LOIC V, Ooteghem Genevieve V, Ariane R, Rita Quaresma Sergio D, et al
    Voluntary versus mechanically-induced deep inspiration breath-hold for left breast cancer: a randomized controlled trial.
    Radiother Oncol. 2023 Mar 8:109598. doi: 10.1016/j.radonc.2023.109598.
    PubMed     Abstract available

    January 2023
  31. LOUISE HOLM MILO M, Slot Moller D, Bisballe Nyeng T, Hoffmann L, et al
    Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation therapy techniques.
    Radiother Oncol. 2023 Jan 12:109453. doi: 10.1016/j.radonc.2022.109453.
    PubMed     Abstract available

    December 2022
  32. WOLFRAM S, S K Takayesu J, Pierce LJ, Jagsi R, et al
    Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: a 12-month follow-up case series.
    Radiother Oncol. 2022 Dec 23:109450. doi: 10.1016/j.radonc.2022.109450.
    PubMed     Abstract available

  33. LEONARDI MC, Cormio CF, Frassoni S, Dicuonzo S, et al
    Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
    Radiother Oncol. 2022;177:71-80.
    PubMed     Abstract available

  34. KAIDAR-PERSON O, Gentilini O, Poortmans P
    Not only volumes matter for breast radiation therapy.
    Radiother Oncol. 2022;177:236-237.

    November 2022
  35. ALGARA M, Rodriguez E, Martinez-Arcelus FJ, Salinas J, et al
    OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial.
    Radiother Oncol. 2022;176:76-82.
    PubMed     Abstract available

    October 2022
  36. VISANI L, Livi L, Ratosa I, Orazem M, et al
    Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer.
    Radiother Oncol. 2022;177:40-45.
    PubMed     Abstract available

  37. GRAADAL SVESTAD J, Heydari M, Gyland Mikalsen S, Gordon Flote V, et al
    Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial.
    Radiother Oncol. 2022 Oct 26. pii: S0167-8140(22)04512.
    PubMed     Abstract available

  38. THOMSEN MS, Alsner J, Nielsen HM, Jakobsen EH, et al
    Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial.
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04494.
    PubMed     Abstract available

  39. LAZZARI G, Rago L, Solazzo AP, Benevento I, et al
    Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: is it time to rethink the sequencing ?
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04507.

  40. VROU OFFERSEN B, Overgaard M, Overgaard J
    Breast cancer radiotherapy: is it time to rethink the indication?
    Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04505.

  41. PATEL CG, Peterson J, Aznar M, Tseng YD, et al
    Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
    Radiother Oncol. 2022 Oct 14. pii: S0167-8140(22)04497.
    PubMed     Abstract available

  42. TUDDA A, Castriconi R, Benecchi G, Cagni E, et al
    Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields.
    Radiother Oncol. 2022;175:10-16.
    PubMed     Abstract available

    September 2022
  43. GOEL V, Sharma D, Sharma A, Mallick S, et al
    A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer.
    Radiother Oncol. 2022;176:59-67.
    PubMed     Abstract available

  44. MULLIEZ T, De Ridder M
    Pre-OPerative Accelerated breast Radio Therapy (POPART): a largely unknown world.
    Radiother Oncol. 2022;174:170.

  45. CHAKRABORTY S, Chatterjee S
    HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis.
    Radiother Oncol. 2022;174:59-68.
    PubMed     Abstract available

    July 2022
  46. IATI G, Tuscano C, Al Sayyad S
    Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study" by Mulliez et al. (March 2022, Volume 170).
    Radiother Oncol. 2022 Jul 8. pii: S0167-8140(22)04190.

  47. KAIDAR-PERSON O, Fortpied C, Hol S, Weltens C, et al
    The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.
    Radiother Oncol. 2022;172:99-110.
    PubMed     Abstract available

    June 2022
  48. CHEVLI N, Haque W, Tran KT, Farach AM, et al
    21- gene recurrence score predictive for prognostic benefit of radiotherapy in patients age >/=70 with T1N0 ER/PR+ HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Radiother Oncol. 2022 Jun 27. pii: S0167-8140(22)04174.
    PubMed     Abstract available

  49. MIRJOLET C, Diallo I, Bertaut A, Veres C, et al
    Treatment related factors associated with the risk of breast radio-induced-sarcoma.
    Radiother Oncol. 2022;171:14-21.
    PubMed     Abstract available

    May 2022
  50. ALMBERG SS, Lervag C, Frengen J, Eidem M, et al
    Training, validation, and clinical implementation of a deep-learning segmentation model for radiotherapy of loco-regional breast cancer.
    Radiother Oncol. 2022 May 23. pii: S0167-8140(22)02269.
    PubMed     Abstract available

    April 2022
  51. BUELENS P, Ir SW, I LV, Crijns W, et al
    Clinical Evaluation of a Deep Learning Model for Segmentation of Target Volumes in Breast Cancer Radiotherapy.
    Radiother Oncol. 2022 Apr 18. pii: S0167-8140(22)00221.
    PubMed     Abstract available

  52. FATTAHI S, Mullikin TC, Aziz KA, Afzal A, et al
    Proton therapy for the treatment of inflammatory breast cancer.
    Radiother Oncol. 2022 Apr 15. pii: S0167-8140(22)00189.
    PubMed     Abstract available

    March 2022
  53. BEDDOK A, Kirova Y, Laki F, Reyal F, et al
    The place of the boost in the breast cancer treatment: State of art.
    Radiother Oncol. 2022 Mar 17. pii: S0167-8140(22)00146.
    PubMed     Abstract available

  54. OVERGAARD M, Nielsen HM, Tramm T, Hojris I, et al
    Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00133.
    PubMed     Abstract available

  55. MULLIEZ T, Miedema G, Van Parijs H, Hottat N, et al
    Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): a feasibility study.
    Radiother Oncol. 2022 Mar 4. pii: S0167-8140(22)00117.
    PubMed     Abstract available

  56. JOO JH, Yang JD, Park HY, Park J, et al
    The patterns and spatial locations of local recurrence in breast cancer with implant-based reconstruction after mastectomy.
    Radiother Oncol. 2022 Mar 1. pii: S0167-8140(22)00113.
    PubMed     Abstract available

    February 2022
  57. CHAN J, Brown E, Dennis K, Milosevic M, et al
    Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
    Radiother Oncol. 2022;167:122-126.
    PubMed     Abstract available

    January 2022
  58. LEONARDI MC, Pepa M, Luraschi R, Vigorito S, et al
    The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: an AIRO multi-institutional study.
    Radiother Oncol. 2022 Jan 13. pii: S0167-8140(22)00008.
    PubMed     Abstract available

  59. GAIDE O, Herrera F, Sozzi WJ, Goncalves Jorge P, et al
    Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
    Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09093.
    PubMed     Abstract available

  60. LADBURY C, Liu J, Radany E, Vora N, et al
    An examination of nationwide trends in accelerated partial breast irradiation - The replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation.
    Radiother Oncol. 2022;166:79-87.
    PubMed     Abstract available

    December 2021
  61. BAKKER A, Valverde CPT, van Tienhoven G, Kolff MW, et al
    Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: temperature matters.
    Radiother Oncol. 2021 Dec 29. pii: S0167-8140(21)09084.
    PubMed     Abstract available

  62. GROOT KOERKAMP ML, van der Leij F, van 't Westeinde T, Bol GH, et al
    Prone vs. supine accelerated partial breast irradiation on an MR-Linac: A planning study.
    Radiother Oncol. 2021;165:193-199.
    PubMed     Abstract available

    November 2021
  63. KAO YS
    Comment to "long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost".
    Radiother Oncol. 2021 Nov 29. pii: S0167-8140(21)09012.

  64. PRICE AT, Kennedy WR, Henke LE, Brown SR, et al
    Implementing stereotactic accelerated partial breast irradiation using magnetic resonance guided radiation therapy.
    Radiother Oncol. 2021;164:275-281.
    PubMed     Abstract available

  65. BOURGIER C, Cowen D, Castan F, Lemanski C, et al
    Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.
    Radiother Oncol. 2021;164:57-65.
    PubMed     Abstract available

  66. DECESARIS CM, Mossahebi S, Jatczak J, Rao AD, et al
    Outcomes of and treatment planning considerations for a hybrid technique delivering proton pencil-beam scanning radiation to women with metal-containing tissue expanders undergoing post-mastectomy radiation.
    Radiother Oncol. 2021;164:289-298.
    PubMed     Abstract available

    October 2021
  67. ISABELLE CHOI J, Khan AJ, Powell SN, McCormick B, et al
    Proton Reirradiation for Recurrent or New Primary Breast Cancer in the Setting of Prior Breast Irradiation.
    Radiother Oncol. 2021 Oct 21. pii: S0167-8140(21)08777.
    PubMed     Abstract available

  68. IMANE A, Gestel Dirk V, Olga K, Carine K, et al
    Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: differences between tangential beam and VMAT.
    Radiother Oncol. 2021 Oct 11. pii: S0167-8140(21)08761.
    PubMed     Abstract available

  69. DUANE FK, Kerr A, Wang Z, Darby SC, et al
    Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
    Radiother Oncol. 2021 Oct 6. pii: S0167-8140(21)08753.
    PubMed     Abstract available

  70. VIANI GA, Gouveia AG, Louie AV, Korzeniowski M, et al
    Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis.
    Radiother Oncol. 2021 Oct 5. pii: S0167-8140(21)08752.
    PubMed     Abstract available

  71. ROJAS DP, Leonardi MC, Frassoni S, Morra A, et al
    Implant risk failure in patients undergoing postmastectomy 3-week hypofractionated radiotherapy after immediate reconstruction.
    Radiother Oncol. 2021;163:105-113.
    PubMed     Abstract available

  72. SPOOR DS, Sijtsema NM, van den Bogaard VAB, van der Schaaf A, et al
    Validation of separate multi-atlases for auto segmentation of cardiac substructures in CT-scans acquired in deep inspiration breath hold and free breathing.
    Radiother Oncol. 2021;163:46-54.
    PubMed     Abstract available

    September 2021
  73. KAIDAR-PERSON O, Dahn HM, Nichol AM, Boersma LJ, et al
    A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer.
    Radiother Oncol. 2021 Sep 23. pii: S0167-8140(21)06735.
    PubMed     Abstract available

  74. HAQUE W, Singh A, Verma V, Schwartz MR, et al
    Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
    Radiother Oncol. 2021;162:52-59.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.